Exhibit 10.1
SYNERGY PHARMACEUTICALS,
INC.
SECURITIES PURCHASE
AGREEMENT
This Securities Purchase Agreement
(this “ Agreement “) is dated as of
, 2009
among Synergy Pharmaceuticals, Inc., a Florida corporation
(the “ Company ”), and each purchaser identified
on the signature pages hereto (each, including its successors
and assigns, a “ Investor “ and collectively the
“ Investors ”).
WHEREAS, subject to the terms and
conditions set forth in this Agreement and pursuant to
Section 4(2) of the Securities Act of 1933, as amended
(the “Securities Act”) and Rule 506 promulgated
thereunder, the Company desires to issue and sell to each Investor
(the “Offering”), and each Investor, severally and not
jointly, desires to purchase from the Company, securities of the
Company as more fully described in this Agreement.
NOW, THEREFORE, IN CONSIDERATION of
the mutual covenants contained in this Agreement, and for other
good and valuable consideration the receipt and adequacy of which
are hereby acknowledged, the Company and each Investor agree as
follows:
SECTION 1
.
1.1
Subscription
. The Company is offering a
maximum of 20,000,000 shares of common stock, $.0001 par value, of
the Company (the “Common Stock”). The Investor,
intending to be legally bound, hereby irrevocably subscribes for
and agrees to purchase the number of shares (the
“Shares”) of the Common Stock, indicated on the
signature page hereof, on the terms and conditions described
herein. All fractional shares will be rounded up or down to
the nearest whole number.
1.2
Purchase of Shares
. The Investor understands and
acknowledges that the purchase price per Share to be remitted to
the Company in exchange for the Shares is $0.70. The Investor
or the Investor’s agent has deposited the Subscription Amount
(defined below) in an interest bearing escrow account. There is a
minimum investment of $50,000 or such smaller amount in the sole
discretion of the Company.
SECTION 2
.
2.1
Acceptance or
Rejection .
(a)
The Investor understands and agrees
that the Company reserves the right to reject this subscription for
the Shares in whole or part in any order, if, in its reasonable
judgment, it deems such action in the best interest of the Company,
at any time prior to the Closing, notwithstanding prior receipt by
the Investor of notice of acceptance of the Investor’s
subscription.
(b)
The Investor understands and agrees
that subscriptions may be revoked provided that written notice of
revocation is sent by certified or registered mail, return receipt
requested, and is received by the Company at least two business
days prior to the Closing.
(c)
In the event (i) of rejection
of this subscription, or (ii) the sale of the Shares
subscribed for by the Investor is not consummated by the Company
for any reason by March 31, 2009, which date may be extended
by the Company, this Subscription Agreement and any other agreement
entered into between the Investor and the Company relating to this
subscription shall thereafter have no force or effect and the
Company shall promptly return or cause to be returned to the
Investor the purchase price remitted in accordance with clause 1.2
by the Investor, without interest thereon or deduction therefrom,
in exchange for the Shares.
2.2
Closing . The closing (the “Closing”)
of the purchase and sale of any of the Shares, following the
acceptance by the Company of the Investors’ subscriptions for
not less than the Minimum Offering has, as evidenced by the
Company’s execution of this Subscription Agreement, shall
take place at the principal offices of Sichenzia Ross Friedman
Ference LLP, counsel to the Company, at 61 Broadway, 32
nd Floor, New York, New York 10006, or such
other place as determined by the Company, on such date (the
“Closing Date”) as is determined by the Company. At the
Closing of the purchase and sale of the Shares subscribed to by the
Investors, the Company shall prepare for delivery to the Investors
the certificates for the securities to be issued and sold to the
Investors, duly registered in the Investor’s name against
payment in full by the Investor in accordance with clause
1.2. Additional Closings will be held until the Maximum
Offering has been achieved or the Offering has
terminated.
SECTION 3
.
3.1
Investor Representations and
Warranties .
The Investor hereby acknowledges,
represents and warrants to, and agrees with, the Company and its
affiliates as follows:
(a)
The Investor is acquiring the Shares
for his or its own account as principal, not as a nominee or agent,
for investment purposes only, and not with a view to, or for,
resale, distribution or fractionalization thereof in whole or in
part and no other person has a direct or indirect beneficial
interest in such Shares or any of the components of the
Shares. Further, the Investor does not have any contract,
undertaking, agreement or arrangement with any person to sell,
transfer or grant participations to such person or to any third
person, with respect to any of the Shares for which the Investor is
subscribing.
(b)
The Investor has full power and
authority to enter into this Agreement, the execution and delivery
of this Agreement has been duly authorized, if applicable, and this
Agreement constitutes a valid and legally binding obligation of the
Investor.
(c)
The Investor acknowledges its
understanding that the offering and sale of the Shares is intended
to be exempt from registration under the Securities Act of 1933, as
amended (the “Securities Act”) by virtue of
Section 4(2) of the Securities Act and the provisions of
Regulation D promulgated thereunder (“Regulation
D”). In furtherance thereof, the Investor represents
and warrants to and agrees with the Company and its affiliates as
follows:
(i)
The Investor realizes that the basis
for the exemption may not be present if, notwithstanding such
representations, the Investor has in mind merely acquiring Shares
for a fixed or determinable period in the future, or for a market
rise, or for sale if the market does not rise. The Investor
does not have any such intention.
(ii)
The Investor has the financial
ability to bear the economic risk of his investment, has adequate
means for providing for his current needs and personal
contingencies and has no need for liquidity with respect to his
investment in the Company;
(iii)
(insert name of Investor Representative: if none, so state )
has acted as the Investor’s Investor Representative for
purposes of the private placement exemption under the Securities
Act. If the Investor has appointed a Investor Representative
(which term is used herein with the same meaning as given in
Rule 501(h) of Regulation D), the Investor has been
advised by his Investor Representative as to the merits and risks
of an investment in the Company in general and the suitability of
an investment in the Shares for the Investor in particular;
and
(iv)
The Investor (together with his
Investor Representative(s), if any) has such knowledge and
experience in financial and business matters as to be capable of
evaluating the merits and risks of the prospective investment in
the Shares. If other than an individual, the Investor also
represents it has not been organized for the purpose of acquiring
the Shares.
(d)
The information in the Accredited
Investor Questionnaire completed and executed by the Investor is
substantially in the form of the Accredited Investor Questionnaire
(the “Accredited Investor Questionnaire”) and is
accurate and true in all respects and the Investor is an
“accredited investor,” as that term is defined in
Rule 501 of Regulation D.
(e)
The Investor and his Investor
Representative, if any, have:
(i)
had access to and carefully reviewed
the Company’s SEC Documents and other public filings, the
Schedules and Exhibits to this Agreement and has had on opportunity
for a reasonable period of time prior to the date hereof to obtain
additional information concerning the offering of the Shares, the
Company, and all other information to the extent the Company
possesses such information or can acquire it without unreasonable
effort or expense;
(iii)
been given the opportunity for a
reasonable period of time prior to the date hereof to ask questions
of, and receive answers from, the Company or its representatives
concerning the terms and conditions of the offering of the Shares
and other matters pertaining to this investment, and have been
given the opportunity for a reasonable period of time prior to the
date hereof to obtain such additional information necessary to
verify the accuracy of the information provided in order for him to
evaluate the merits and risks of purchase of the
Shares to the extent the Company
possesses such information or can acquire it without unreasonable
effort or expense;
(iv)
not been furnished with any oral
representation or oral information in connection with the offering
of the Shares which is not contained herein; and
(v)
determined that the Shares are a
suitable investment for the Investor and that at this time the
Investor could bear a complete loss of such investment.
(f)
The Investor is not relying on the
Company, or its affiliates with respect to economic considerations
involved in this investment. The Investor has relied on the
advice of, or has consulted with only those persons, if any, named
as Investor Representative(s) herein and in the Accredited
Investor Questionnaire. Each Investor Representative is
capable of evaluating the merits and risks of an investment in the
Shares on the terms and conditions set forth herein and each
Investor Representative has disclosed to the Investor in writing (a
copy of which is annexed to this Agreement) the specific details of
any and all past, present or future relationships, actual or
contemplated, between himself and the Company or any affiliate or
subsidiary thereof.
(g)
The Investor represents, warrants
and agrees that he will not sell or otherwise transfer the Shares
without registration under the Securities Act or an exemption
therefrom and fully understands and agrees that he must bear the
economic risk of his purchase because, among other reasons, the
Shares have not been registered under the Securities Act or under
the securities laws of any state and, therefore, cannot be resold,
pledged, assigned or otherwise disposed of unless they are
subsequently registered under the Securities Act and under the
applicable securities laws of such states or an exemption from such
registration is available. In particular, the Investor is
aware that the Shares are “restricted securities,” as
such term is defined in Rule 144 promulgated under the
Securities Act (“ Rule 144 ”), and they may
not be sold pursuant to Rule 144 unless all of the conditions
of Rule 144 are met. The Investor also understands that,
except as otherwise provided herein and in the certificates for the
Shares, the Company is under no obligation to register the Shares
on his behalf or to assist him in complying with any exemption from
registration under the Securities Act or applicable state
securities laws. The Investor further understands that sales
or transfers of the Shares are further restricted by state
securities laws and the provisions of this Agreement.
(h)
No representations or warranties
have been made to the Investor by the Company, or any officer,
employee, agent, affiliate or subsidiary of the Company, other than
the representations of the Company contained herein, and in
subscribing for Shares the Investor is not relying upon any
representations other than those contained herein. Investor
has carefully reviewed filings made by the Company with the U.S.
Securities and Exchange Commission and the Company’s
Confidential Private Placement Memorandum dated February 2,
2009.
(i)
Any information which the Investor
has heretofore furnished to the Company with respect to his
financial position and business experience is correct and complete
as of the date of this Agreement and if there should be any
material change in such information he will immediately furnish
such revised or corrected information to the Company.
(j)
The Investor understands and agrees
that the certificates for the Shares shall bear the following
legend until (i) such securities shall have been registered
under the Securities Act and effectively been disposed of in
accordance with a registration statement that has been declared
effective; or (ii) in the opinion of counsel for the Company
such securities may be sold without registration under the
Securities Act as well as any applicable “Blue Sky” or
state securities laws. Accordingly the Investor understands
and consents that the certificates representing the Shares, in
addition to any notation required by law or by this Agreement,
shall have the following legend:
“THESE SECURITIES HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“SECURITIES ACT”), AND MAY NOT BE OFFERED, SOLD,
PLEDGED, HYPOTHECATED, ASSIGNED OR TRANSFERRED EXCEPT
(i) PURSUANT TO A REGISTRATION STATEMENT UNDER THE SECURITIES
ACT WHICH HAS BECOME EFFECTIVE AND IS CURRENT WITH RESPECT TO THESE
SECURITIES, OR (ii) PURSUANT TO A SPECIFIC EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT BUT ONLY UPON A HOLDER HEREOF
FIRST HAVING OBTAINED THE WRITTEN OPINION OF COUNSEL TO THE
CORPORATION, OR OTHER COUNSEL REASONABLY ACCEPTABLE TO THE
CORPORATION, THAT THE PROPOSED DISPOSITION IS CONSISTENT WITH ALL
APPLICABLE PROVISIONS OF THE SECURITIES ACT AS WELL AS ANY
APPLICABLE “BLUE SKY” OR SIMILAR SECURITIES
LAW.”
(k)
The Investor understands that an
investment in the Shares is a speculative investment which involves
a high degree of risk and the potential loss of his entire
investment.
(l)
The Investor’s overall
commitment to investments which are not readily marketable is not
disproportionate to the Investor’s net worth, and an
investment in the Shares will not cause such overall commitment to
become excessive.
(m)
Investor is not purchasing the
Shares as a result of any advertisement, article, notice or other
communication regarding the Securities published in any newspaper,
magazine or similar media or broadcast over television or radio or
presented at any seminar or any other general solicitation or
general advertisement.
(n)
Other than the transaction
contemplated hereunder, such Investor has not directly or
indirectly, nor has any person acting on behalf of or pursuant to
any understanding with such Investor, executed any disposition,
including Short Sales (defined below), in the securities of
the Company during the period commencing from the time that such
Investor first received a term sheet from the Company or any other
person setting forth the material terms of the transactions
contemplated hereunder until the date hereof (“ Discussion
Time ”). Notwithstanding the foregoing, in the case
of a Investor that is a multi-managed investment vehicle whereby
separate portfolio managers manage separate portions of such
Purchaser’s assets and the portfolio managers have no direct
knowledge of the investment decisions made by the portfolio
managers managing other portions of such Investor’s assets,
the representation set forth above shall only apply with respect to
the portion of assets managed by the portfolio manager
that made the investment decision to purchase
the Shares covered by this Agreem